2.5
2025

Efficacy and safety of mepolizumab in hypereosinophilic syndrome

Show more: Authors information and Publication history
Authors Information

Allergy and Immunology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

History

Published: 20 May 2026
Accepted: 29 April 2026
Received: 20 January 2026

KEY WORDS
Hypereosinophilic syndrome; Mepolizumab; eosinophil.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology | ©2026
Online ISSN: 2845-7285 (since 2024) · Print ISSN: 1764-1489 (discontinued in 2023)